Budget impact analysis of breast cancer medications: a systematic review

ConclusionResearchers should conduct the budget impact analysis of high-value medications such as anti-tumor drugs more objectively, and the accuracy of parameters needs to be more strictly guaranteed. Furthermore, it is worthy of declaring that the budgetary impact of the same drug is not always consistent over time, so the researchers should measure access to medication in the long run.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research